-
November 9, 2022 Lupin Q2 FY2023 Results
-
November 8, 2022 Lupin Receives Tentative Approval from U.S. FDA for Doxycycline Capsules
-
November 4, 2022 Lupin Receives Tentative Approval from U.S. FDA for Drospirenone Tablets
-
October 20, 2022 Lupin Launches Paliperidone Extended-Release Tablets in the United States
-
October 20, 2022 Lupin Signs Agreement to Acquire Two Inhalation Brands from Sunovion
-
October 7, 2022 Lupin Partners with Global Agencies to Increase Patient Access to Tuberculosis Prevention Treatment
-
October 7, 2022 Lupin Appoints Dr. Shahin Fesharaki as Global Chief Scientific Officer
-
October 4, 2022 Lupin Receives Approval from U.S. FDA for Darunavir Tablets
-
October 1, 2022 Lupin Life announces association with Vikram Vedha as official energy partner with its Be One health and wellness supplement
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications